CRISPR Patent Ruling May Push Warring Sides To A Deal

The Federal Circuit's decision Monday rejecting the University of California's efforts to secure control over patents on the breakthrough gene-editing system CRISPR in a fight with the Broad Institute leaves an...

Already a subscriber? Click here to view full article